title: Health care consumers' perspectives on pharmacist integration into private general practitioner clinics in Malaysia: a qualitative study.
abstract: BACKGROUND
  Pharmacists are considered medication experts but are underutilized and exist mainly at the periphery of the Malaysian primary health care team. Private general practitioners (GPs) in Malaysia are granted rights under the Poison Act 1952 to prescribe and dispense medications at their primary care clinics. As most consumers obtain their medications from their GPs, community pharmacists' involvement in ensuring safe use of medicines is limited. The integration of a pharmacist into private GP clinics has the potential to contribute to quality use of medicines. This study aims to explore health care consumers' views on the integration of pharmacists within private GP clinics in Malaysia.
  
  
  METHODS
  A purposive sample of health care consumers in Selangor and Kuala Lumpur, Malaysia, were invited to participate in focus groups and semi-structured interviews. Sessions were audio recorded and transcribed verbatim and thematically analyzed using NVivo 10.
  
  
  RESULTS
  A total of 24 health care consumers participated in two focus groups and six semi-structured interviews. Four major themes were identified: 1) pharmacists' role viewed mainly as supplying medications, 2) readiness to accept pharmacists in private GP clinics, 3) willingness to pay for pharmacy services, and 4) concerns about GPs' resistance to pharmacist integration. Consumers felt that a pharmacist integrated into a private GP clinic could offer potential benefits such as to provide trustworthy information on the use and potential side effects of medications and screening for medication misadventure. The potential increase in costs passed on to consumers and GPs' reluctance were perceived as barriers to integration.
  
  
  CONCLUSIONS
  This study provides insights into consumers' perspectives on the roles of pharmacists within private GP clinics in Malaysia. Consumers generally supported pharmacist integration into private primary health care clinics. However, for pharmacists to expand their capacity in providing integrated and collaborative primary care services to consumers, barriers to pharmacist integration need to be addressed.
authors.affiliation: School of Postgraduate Studies and Research, International Medical University, Kuala Lumpur, Malaysia.
authors.forename: Pui San
authors.initials: PS
authors.lastname: Saw
authors.affiliation: School of Clinical Sciences, Queensland University Technology, Brisbane, QLD, Australia ; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Nissen
authors.affiliation: School of Clinical Sciences, Queensland University Technology, Brisbane, QLD, Australia ; School of Pharmacy, University of Queensland, St Lucia, QLD, Australia.
authors.forename: Christopher
authors.initials: C
authors.lastname: Freeman
authors.affiliation: School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
authors.forename: Pei Se
authors.initials: PS
authors.lastname: Wong
authors.affiliation: School of Pharmacy, Monash University Malaysia, Selangor, Malaysia.
authors.forename: Vivienne
authors.initials: V
authors.lastname: Mak
keywords: Malaysia; general practitioners; health care consumer; pharmacist integration; private clinic
references.citation: BMJ Open. 2013 Sep 11;3(9):e003214
references.pmid: 24030867
references.citation: Fam Pract. 2001 Oct;18(5):534-6
references.pmid: 11604378
references.citation: Int J Pharm Pract. 2014 Feb;22(1):28-37
references.pmid: 23750666
references.citation: J Interprof Care. 2008 Aug;22(4):387-98
references.pmid: 18800280
references.citation: Br J Gen Pract. 1999 May;49(442):343-7
references.pmid: 10736882
references.citation: Health Technol Assess. 2002;6(20):1-86
references.pmid: 12234455
references.citation: Asia Pac J Public Health. 2002;14(1):17-22
references.pmid: 12597513
references.citation: Int J Pharm Pract. 2012 Dec;20(6):395-401
references.pmid: 23134099
references.citation: Soc Sci Med. 2001 Oct;53(7):943-55
references.pmid: 11522139
references.citation: Int J Pharm Pract. 2013 Feb;21(1):66-9
references.pmid: 23301536
references.citation: Ann Pharmacother. 2005 Oct;39(10):1720-5
references.pmid: 16144881
references.citation: Drugs Aging. 2008;25(11):947-54
references.pmid: 18947262
references.citation: Age Ageing. 2001 May;30(3):205-11
references.pmid: 11443021
references.citation: Med J Malaysia. 2009 Mar;64(1):46-50
references.pmid: 19852321
references.citation: Arch Intern Med. 2000 Jul 24;160(14):2129-34
references.pmid: 10904455
references.citation: Clin Pharmacol Ther. 2008 Jun;83(6):913-7
references.pmid: 18388882
references.citation: Br J Gen Pract. 1991 Mar;41(344):116-8
references.pmid: 2031755
references.citation: Postgrad Med J. 2001 Nov;77(913):703-7
references.pmid: 11677279
references.citation: Arch Intern Med. 2002 May 27;162(10):1149-55
references.pmid: 12020186
references.citation: Pharm Pract (Granada). 2010 Oct;8(4):250-4
references.pmid: 25126149
references.citation: Br J Clin Pharmacol. 2009 May;67(5):547-57
references.pmid: 19552750
references.citation: BMJ. 2001 Dec 8;323(7325):1340-3
references.pmid: 11739221
references.citation: Arch Intern Med. 2009 Nov 23;169(21):1996-2002
references.pmid: 19933962
references.citation: J Am Pharm Assoc (2003). 2003 May-Jun;43(3):424-33; quiz 433-4
references.pmid: 12836796
references.citation: Br J Gen Pract. 2003 Aug;53(493):600-6
references.pmid: 14601335
references.citation: BMC Health Serv Res. 2012 Aug 01;12:229
references.pmid: 22852792
references.citation: J Young Pharm. 2011 Jul;3(3):250-5
references.pmid: 21897668
references.citation: BMJ Open. 2012 May 14;2(3):null
references.pmid: 22586286
references.citation: J Formos Med Assoc. 2014 Feb;113(2):106-13
references.pmid: 24530244